Literature DB >> 26941864

FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis.

Axel Van Der Gucht1, Mehdi Aoun-Sebaiti2, Paul Kauv3, Eric Guedj4, Jessie Aouizerate5, Antoine Verger6, Romain K Gherardi5, Anne-Catherine Bachoud-Levi7, François-Jérôme Authier5, Emmanuel Itti1.   

Abstract

Brain Positron Emission Tomography/Computed Tomography with (18)F-fluorodeoxyglucose (FDG PET/CT) was performed in a 44-year-old woman with marked cognitive impairment, diffuse myalgias, sensory, memory and visual disorders, and chronic fatigue, presenting with histopathological features of macrophagic myofasciitis (MMF) at deltoid muscle biopsy. Cerebromedullary Magnetic Resonance Imaging (MRI), electromyography, ophthalmic examination, and cerebrospinal fluid analysis were normal. Visual analysis of FDG PET/CT images showed an atypical pattern of hypometabolism, involving symmetrically the occipital cortex, temporal lobes, and limbic system (including in particular amygdalo-hippocampal complexes), and the cerebellum. Posterior cingulate cortex and parietal areas were preserved. This pattern was confirmed by a voxel-based procedure using Statistical Parametric Mapping (SPM12) that compared a patient's images to normal reference samples from six healthy subjects with adjustment to age obtained using the same PET/CT camera. These results provide a glucose metabolism substrate for cognitive complaints in patients with long-lasting aluminium hydroxide-induced MMF.

Entities:  

Keywords:  18F-FDG; Aluminum hydroxide; Brain imaging; Macrophagic myofasciitis

Year:  2015        PMID: 26941864      PMCID: PMC4762870          DOI: 10.1007/s13139-015-0371-z

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  10 in total

Review 1.  A cortical-hippocampal system for declarative memory.

Authors:  H Eichenbaum
Journal:  Nat Rev Neurosci       Date:  2000-10       Impact factor: 34.870

2.  Chronic fatigue syndrome in patients with macrophagic myofasciitis.

Authors:  François-Jérôme Authier; Stéphane Sauvat; Julien Champey; Irène Drogou; Michèle Coquet; Romain K Gherardi
Journal:  Arthritis Rheum       Date:  2003-02

3.  Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space.

Authors:  J D Schmahmann; J Doyon; D McDonald; C Holmes; K Lavoie; A S Hurwitz; N Kabani; A Toga; A Evans; M Petrides
Journal:  Neuroimage       Date:  1999-09       Impact factor: 6.556

4.  Macrophagic myofasciitis and vaccination: consequence or coincidence?

Authors:  Tânia Santiago; Olinda Rebelo; Luís Negrão; Anabela Matos
Journal:  Rheumatol Int       Date:  2014-06-13       Impact factor: 2.631

5.  Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.

Authors:  R K Gherardi; M Coquet; P Cherin; L Belec; P Moretto; P A Dreyfus; J F Pellissier; P Chariot; F J Authier
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

6.  Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

Authors:  R K Gherardi; M Coquet; P Chérin; F J Authier; P Laforêt; L Bélec; D Figarella-Branger; J M Mussini; J F Pellissier; M Fardeau
Journal:  Lancet       Date:  1998-08-01       Impact factor: 79.321

7.  Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.

Authors:  Maryline Couette; Marie-Françoise Boisse; Patrick Maison; Pierre Brugieres; Pierre Cesaro; Xavier Chevalier; Romain K Gherardi; Anne-Catherine Bachoud-Levi; François-Jérôme Authier
Journal:  J Inorg Biochem       Date:  2009-08-20       Impact factor: 4.155

8.  Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis.

Authors:  Axel Van Der Gucht; Mehdi Aoun Sebaiti; Emmanuel Itti; Jessie Aouizerate; Eva Evangelista; Julia Chalaye; Romain K Gherardi; Nilusha Ragunathan-Thangarajah; Anne-Catherine Bachoud-Levi; François-Jérôme Authier
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 9.  Clinical features in patients with long-lasting macrophagic myofasciitis.

Authors:  Muriel Rigolet; Jessie Aouizerate; Maryline Couette; Nilusha Ragunathan-Thangarajah; Mehdi Aoun-Sebaiti; Romain Kroum Gherardi; Josette Cadusseau; François Jérôme Authier
Journal:  Front Neurol       Date:  2014-11-28       Impact factor: 4.003

10.  Slow CCL2-dependent translocation of biopersistent particles from muscle to brain.

Authors:  Zakir Khan; Christophe Combadière; François-Jérôme Authier; Valérie Itier; François Lux; Christopher Exley; Meriem Mahrouf-Yorgov; Xavier Decrouy; Philippe Moretto; Olivier Tillement; Romain K Gherardi; Josette Cadusseau
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

  10 in total
  3 in total

1.  Macrophagic myofasciitis: a challenging diagnosis.

Authors:  Daniela Soares Santos; Arsénio Santos; Olinda Rebelo; Rui M Santos
Journal:  BMJ Case Rep       Date:  2018-07-03

2.  Predictive value of brain 18F-FDG PET/CT in macrophagic myofasciitis?: A case report.

Authors:  Axel Van Der Gucht; Mukedaisi Abulizi; Paul Blanc-Durand; Mehdi Aoun-Sebaiti; Berivan Emsen; Romain K Gherardi; Antoine Verger; François-Jérôme Authier; Emmanuel Itti
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

3.  Cerebral 18F-FDG PET in macrophagic myofasciitis: An individual SVM-based approach.

Authors:  Paul Blanc-Durand; Axel Van Der Gucht; Eric Guedj; Mukedaisi Abulizi; Mehdi Aoun-Sebaiti; Lionel Lerman; Antoine Verger; François-Jérôme Authier; Emmanuel Itti
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.